TGTX
TG Therapeutics Inc
Price:  
24.50 
USD
Volume:  
2,188,754.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TGTX WACC - Weighted Average Cost of Capital

The WACC of TG Therapeutics Inc (TGTX) is 7.5%.

The Cost of Equity of TG Therapeutics Inc (TGTX) is 7.55%.
The Cost of Debt of TG Therapeutics Inc (TGTX) is 8.20%.

Range Selected
Cost of equity 6.50% - 8.60% 7.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.60% - 11.80% 8.20%
WACC 6.4% - 8.6% 7.5%
WACC

TGTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.58 0.67
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 8.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.03 0.03
Cost of debt 4.60% 11.80%
After-tax WACC 6.4% 8.6%
Selected WACC 7.5%